Healthcare

Growth Opportunities in Single Cell Genomics and Proteomics in the United States Updated Research Available

Public Funding and Large Biopharma Investments Support Technological Advancements and Improved Analysis

INDUSTRY
Healthcare

RELEASE DATE
08-Dec-2023
REGION
North America
DELIVERABLE TYPE
Market Research

RESEARCH CODE
K998-01-00-00-00
SKU
HC_2023_402
Yes
SHARE

Growth Opportunities in Single Cell Genomics and Proteomics in the United States
Published on: 08-Dec-2023 | SKU: HC_2023_402

Need more details?

$4,950.00

$3,712.50 save 25 %

DownloadLink
Need more details?

In recent years, single-cell analysis has changed rapidly. It began as a niche, specialized technology with few companies offering solutions, which then became commonly used in academia. Subsequently, its use has spread to areas such as biopharma, with more companies investing in the research and development (R&D) of single-cell analysis projects.

Globally, the single-cell genomics and proteomics market is growing at high rates. The United States represents about 60% of the total market and is on track to increase about 12% to 16% annually. Much of that growth is characterized by public funding, such as funding by the National Institutes of Health (NIH) and increasing biopharma investments. Greater adoption and better handling of artificial intelligence (AI) and machine learning (ML) tools will drive this market’s growth. These novel tools encourage the development of software and data analysis solutions to help researchers interpret data.

This report examines the US single-cell genomics and proteomics market and provides a forecast from 2023 to 2028. It assesses the market for single-cell analysis tools used for analytical and isolation purposes across workflows, technologies, and applications. Frost & Sullivan provides information on market concentration and evolution, leading providers, application areas, and technologies. This study will help vendors understand critical trends emerging for various application domains.

Why is it Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top 3 Strategic Imperatives on the US Single-cell Genomics and Proteomics Industry

Growth Opportunities Fuel the Growth Pipeline Engine™

Scope of Analysis

Segmentation

Key Competitors by Workflow

Growth Metrics

Growth Drivers

Growth Drivers (continued)

Growth Restraints

Forecast Assumptions

Revenue Forecast

Revenue Forecast Analysis

Revenue Forecast Analysis (continued)

Revenue Forecast by Workflow

Percent Revenue Forecast by Workflow

Forecast Analysis by Workflow

Revenue Forecast by Application

Percent Revenue Forecast by Application

Forecast Analysis by Application

Revenue Forecast by Technology

Percent Revenue Forecast by Technology

Forecast Analysis by Technology

Forecast Analysis by Technology (continued)

Pricing Trends and Forecast Analysis

Competitive Environment

Revenue Share

Revenue Share Analysis

Revenue Share Analysis (continued)

Key Companies to Watch

Key Companies to Watch (continued)

Company Solutions

Key Technologies and Workflow—Competitor Landscape

Interest in Single-cell Genomics

Single-cell Analysis Workflow Technology

Single-cell Analysis Workflow Technology (continued)

Single-cell Analysis Workflow Technology (continued)

Key Partnerships and Collaborations

Early-stage Company Funding Trends for Single-cell Analysis

Early-stage Company Funding Trends for Single-cell Analysis (continued)

Research Center Funding Trends for Single-cell Analysis

Single-cell Genomics and Proteomics Cores around the World

Growth Opportunity 1: Bioinformatics Tools and Platforms for Analyzing and Interpreting Large-scale Single-cell Data

Growth Opportunity 1: Bioinformatics Tools and Platforms for Analyzing and Interpreting Large-scale Single-cell Data (continued)

Growth Opportunity 2: Automation and High-throughput Solutions for Tissue Dissociation Processes

Growth Opportunity 2: Automation and High-throughput Solutions for Tissue Dissociation Processes (continued)

Growth Opportunity 3: The Integration of Multi-Omics Data to Drive the Development of Personalized Medicine

Growth Opportunity 3: The Integration of Multi-Omics Data to Drive the Development of Personalized Medicine (continued)

Your Next Steps

Why Frost, Why Now?

List of Exhibits

Legal Disclaimer

List of Figures
  • Single-cell Genomics and Proteomics: Growth Metrics, US, 2023
  • Single-cell Genomics and Proteomics: Growth Drivers, US, 2023–2028
  • Single-cell Genomics and Proteomics: Growth Restraints, US, 2023–2028
  • Single-cell Genomics and Proteomics: Revenue Forecast, US, 2023–2028
  • Single-cell Genomics and Proteomics: Revenue Forecast by Workflow, US, 2023–2028
  • Single-cell Genomics and Proteomics: Percent Revenue Forecast by Workflow, US, 2023 and 2028
  • Single-cell Genomics and Proteomics: Revenue Forecast by Application, US, 2023–2028
  • Single-cell Genomics and Proteomics: Percent Revenue Forecast by Application, US, 2023 and 2028
  • Single-cell Genomics and Proteomics: Revenue Forecast by Technology, US, 2023–2028
  • Single-cell Genomics and Proteomics: Percent Revenue Forecast by Technology, US, 2023 and 2028
  • Single-cell Genomics and Proteomics: Revenue Share by Tier Classification, Global, 2023
  • Single-cell Genomics and Proteomics: Competitive Mapping of Important Players’ Capabilities, US, 2023
  • Single-cell Genomics and Proteomics Market: Competitor Landscape, US, 2023
  • Single-cell Genomics and Proteomics Market: Publication Count, Global, 2018–2022
  • Single-cell Genomics and Proteomics Market: Partnership Assessment, US, 2023
  • Single-cell Genomics and Proteomics Market: Early-stage Company Funding for Single Cell Projects, US, 2019–2022
  • Single-cell Genomics and Proteomics Market: Research Center Funding Trends, US, 2019–2022

Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Healthcare research

19 Nov 2026   |   Global   |   Technology Research

Programmable Vaccines: AI-Designed Antigens and Next-Generation Rapid Platforms

Traditional vaccine development is an empirical, time-consuming process that often leads to a high failure rate. With the proven clinical success of RNA vaccines, there has been a focus on accelerating the development of vaccines to address the growing incidence of infectious diseases and emerging p...

17 Nov 2026   |   Global   |   Frost Radar

Frost Radar™: Quantum-Grade Sensor Technology Ecosystem for Healthcare Applications, 2026

Quantum-grade sensors are advancing healthcare by leveraging quantum phenomena to enable highly sensitive, precise, and non-invasive measurements of biological signals and physiological parameters. These innovations enhance diagnostic accuracy, disease monitoring, brain activity measurement, and ear...

16 Nov 2026   |   North America   |   Frost Radar

Frost Radar™: Healthcare Data Interoperability Platforms and Integration Engines in North America, 2026

This Frost Radar™ analyzes the healthcare data platform and integration engine vendors that enable healthcare organization to improve the exchange, utilization, contextualization, and management of clinical, operational, financial, and administrative data. Data issues, AI adoption, and solution gove...

03 Nov 2026   |   North America   |   Market Research

Enterprise Imaging Market, United States, 2025–2030

Enterprise imaging is no longer a technology upgrade. It is becoming the operating model for imaging across the provider organization, and the next investment cycle will decide which vendors lead it. This study gives vendors, ecosystem partners, and provider leaders a 360-degree view of that shift, ...

02 Nov 2026   |   Global   |   Market Research

Continuous Glucose Monitoring Market, Global, 2026

The global continuous glucose monitoring (CGM) market is undergoing a fundamental transformation as the technology evolves from a prescription-led glucose monitoring device into an AI-connected metabolic intelligence ecosystem. Market expansion is increasingly driven by the emergence of over-the-cou...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.